WASHINGTON — Note to would-be Food and Drug Administration commissioners: Stop tweeting!
Two weeks ago the prospects for Silicon Valley’s Balaji Srinivasan faded after his highly critical tweets about the FDA came to public attention. Now, Dr. Joseph Gulfo, whose name surfaced Monday, might have an even trickier problem: His retweets were about President Trump.
